DESTINY-Breast12: T-DXd Exhibits Clinical Activity in HER2+ Breast Cancer Irrespective of Brain Metastases
T-DXd exhibited substantial and durable clinical activity in a large cohort of patients with metastatic HER2+ breast cancer, irrespective of brain metastases, ...